Instylla announces enrollment of initial patient in the prospective multicenter "HALT" Study
The HALT Study at MemorialCare Long Beach Medical Center is intended for the treatment of peripheral arterial bleeds.
Source: oc-breeze.com
Stay updated with breaking news from Jeffrey Leef. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The HALT Study at MemorialCare Long Beach Medical Center is intended for the treatment of peripheral arterial bleeds.
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...